Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing.

Lehmann LS, Kaufman DJ, Sharp RR, Moreno TA, Mountain JL, Roberts JS, Green RC.

Genet Med. 2012 Feb;14(2):268-73. doi: 10.1038/gim.2011.59. Epub 2012 Jan 12.

2.

How industry uses the ICMJE guidelines to manipulate authorship--and how they should be revised.

Matheson A.

PLoS Med. 2011 Aug;8(8):e1001072. doi: 10.1371/journal.pmed.1001072. Epub 2011 Aug 9. No abstract available.

3.

Ethics and the publication of research.

Perlman M.

Paediatr Child Health. 2003 Apr;8(4):215-7. No abstract available.

4.

Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Lanier WL.

Mayo Clin Proc. 2009 Sep;84(9):771-5. doi: 10.1016/S0025-6196(11)60485-0. No abstract available.

5.

Reliability of disclosure forms of authors' contributions.

Ilakovac V, Fister K, Marusic M, Marusic A.

CMAJ. 2007 Jan 2;176(1):41-6.

6.

Conforming to ICMJE principles.

Halperin SA, Scheifele D, Duval B, Ward B.

CMAJ. 2005 Nov 22;173(11):1358-9. No abstract available.

7.

Systematic reviews need systematic searchers.

McGowan J, Sampson M.

J Med Libr Assoc. 2005 Jan;93(1):74-80. Review.

8.

Assessing the bioethical integrity of a clinical trial in surgery.

Bernstein M.

Can J Surg. 2004 Oct;47(5):329-32. No abstract available.

9.

The "file drawer" phenomenon: suppressing clinical evidence.

[No authors listed]

CMAJ. 2004 Feb 17;170(4):437, 439. English, French. No abstract available.

10.

Getting it right: industry sponsorship and medical research.

Baird P.

CMAJ. 2003 May 13;168(10):1267-9. No abstract available.

11.

Toward effective Canadian public-private partnerships in health research.

Bernstein A.

CMAJ. 2003 Feb 4;168(3):288-9. No abstract available.

12.

The controlling interests of research.

[No authors listed]

CMAJ. 2002 Nov 26;167(11):1221, 1223. English, French. No abstract available.

13.

A medical early warning system.

Kassirer JP.

CMAJ. 2002 Apr 30;166(9):1151-2. No abstract available.

14.

Accelerated publication versus usual publication in 2 leading medical journals.

Ghali WA, Cornuz J, McAlister FA, Wasserfallen JB, Devereaux PJ, Naylor CD.

CMAJ. 2002 Apr 30;166(9):1137-43.

15.

Analysis of serious adverse events. Lipid-lowering therapy revisited.

Wright JM, Puil L, Bassett CL.

Can Fam Physician. 2002 Mar;48:486-9, 492-5. Review. English, French. No abstract available.

16.

Ethics and industry-sponsored research.

Pater JL, Parulekar W, O'Callagham C, Shepherd L, Eisenhouer E, Seymour L, Tu D, Ding K.

CMAJ. 2002 Mar 5;166(5):581-2. No abstract available.

17.

Ethics and industry-sponsored research.

Holmer AF.

CMAJ. 2002 Mar 5;166(5):580; author reply 582. No abstract available.

18.

Ethics and industry-sponsored research.

Miettinen OS.

CMAJ. 2002 Mar 5;166(5):580-1; author reply 582. No abstract available.

19.

Ethics and industry-sponsored research.

Loschiavo SR.

CMAJ. 2002 Mar 5;166(5):579; author reply 582. No abstract available.

20.

Ethics and industry-sponsored research.

Kuebler C, Nimmo WS, von R, Gillings D, Morgan AT, Kendle C, Covington PS.

CMAJ. 2002 Mar 5;166(5):579-80; author reply 582. No abstract available.

Supplemental Content

Support Center